Probably end up on the OTC imo. They're bleeding themselves and must realize it by now. I'm not sure they can do a RS and maintain compliance without some serious funding. Which will likely be toxic.
just my guess. But, it can still be playable with the volatility.
Market Data 
Markets 
AI
